Vocal hyperfunction (VH) is the most commonly treated class of voice disorders by speech-language pathologists and voice therapy is the primary curative treatment. Patients and clinicians report that generalizing improved voicing into daily life is the most significant barrier to successful therapy. We will test if extending biofeedback into the patient's daily life using ambulatory voice monitoring will significantly improve generalization during therapy and if individual patient factors, like how easily they can modify their voice and engagement during therapy, moderate the effects of the biofeedback.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Generalization
Timeframe: Before therapy, immediately after therapy, and 6 months after therapy
Stimulability
Timeframe: This will be calculated before therapy begins.
Rehabilitation Treatment Intensity Scale (RITS)
Timeframe: Before therapy, immediately after therapy, and 6 months after therapy
Consensus Auditory Perceptual Evaluation - Voice (CAPE-V)
Timeframe: Before therapy, immediately after therapy, and 6 months after therapy
Voice-Related Quality of Life (V-RQOL)
Timeframe: Before therapy, immediately after therapy, and 6 months after therapy